IPC awards MVP award to Blende Drug of Pueblo, Colo.
Pictured above are IPC president and CEO Don Anderson, IPC board vice chair Vicki Einhellig, MVP John Cernac with his wife Charlotte and son John Jr., and IPC GPO regional account director Jim Sajbel
SUN PRAIRIE, Wis. — Independent Pharmacy Cooperative on Monday named Blende Drug of Pueblo, Colo. and its owner John Cernac as the group's Most Valuable Pharmacy for 2017.
“John Cernac truly embodies the spirit of the cooperative and it is an honor to be able to recognize him for his leadership and dedication to impressive service and care," stated Don Anderson, IPC president and CEO. “Blende Drug is at the heart of their community and a strong voice for independent pharmacy.”
“IPC has exceptional personnel involved in political action, educational opportunities and excellent buying strategies which accounts for our exceptional rebates,” Cernac said. “The MVP Award was a total surprise and a tremendous honor for myself, Charlotte and our staff," he said. "It means a lot to me to know that IPC selected Blende Drug from over 5,000 IPC stores, this accomplishment has made my 58 years as a pharmacist filled with exuberant joy.”
Cernac, his wife Charlotte and son, John Jr. accepted IPC’s MVP Award at the IPC Annual Business Meeting July 14 during McKesson ideaShare 2017 in New Orleans. Cernac first learned of the award during a surprise ceremony held at the pharmacy shortly before McKesson ideaShare.
A pharmacist since 1959, Cernac is active in the National Community Pharmacists Association, the Colorado Pharmacy Association and RxPlus Colorado. He also supports several scholarship programs for the future of independent pharmacists.
He received the Colorado Board of Regents Medal in 1992. Cernac is a past board member for the Blende Sanitation District and the Parish Council.
Cernac purchased Blende Drug in 1972 with partners Ron Yoxey and Nick Giordano. After 11 years, Cernac and his wife Charlotte became the sole owners. They raised two sons and have three grandchildren.
Dating back to 1983, IPC is a group purchasing organization owned by independent pharmacy and represents nearly 6,000 members.
NCPA names 2017 finalists of Good Neighbor Pharmacy NCPA Pruitt-Schutte competition
ALEXANDRIA, Va. — The National Community Pharmacists Association has named the three student teams that will present their business plans at the NCPA Annual Convention as part of the Good Neighbor Pharmacy NCPA Pruitt-Schutte Student Business Plan Competition.
Teams of pharmacy students from the University of Arkansas for Medical Sciences, the University of the Pacific Thomas J. Long School of Pharmacy and the University of Southern California School of Pharmacy have been named the finalists of the annual competition — named for independent community pharmacy champions Neil Pruitt, Sr., and H. Joseph Schutte. The teams will present their business plans in a live competition on Oct. 14 in Orlando.
“NCPA is dedicated to empowering the next generation of independent community pharmacy owners, with our annual student business plan competition being the crown jewel in those efforts,” NCPA President DeAnn Mullins said. “Our panel of experts were impressed by all the business plans that were submitted this year, but we are especially proud of the three teams of finalists who will give live presentations during the competition at NCPA’s Annual Convention in October. Best of luck to the pharmacy students from the University of Arkansas, the University of Pacific and the University of Southern California.”
The team that earns fist place will see $3,000 go to its NCPA chapter and $3,000 contributed to the school in the dean’s name. Second place gets $2,000 for the NCPA student chapter and a $2,000 donation in the dean’s name. Third place received $1,000 for the NCPA student chapter and a $1,000 to the school in the dean’s name.
NCPA said the competition’s goal is to motivate pharmacy students to think of a business model for buying an existing independent pharmacy or opening a new pharmacy. Good Neighbor Pharmacy, Pharmacists Mutual Cos. and the NCPA Foundation sponsor the competition.
The teams that placed in the top 10 all receive a special plate acknowledging the distinction, in addition to the plaque that all participants receive.
The schools in the top 10 were Drake University College of Pharmacy and Health Sciences, University of Maryland School of Pharmacy, University of Missouri Kansas City School of Pharmacy, University of Oklahoma College of Pharmacy, University of Texas at Austin College of Pharmacy, University of Washington School of Pharmacy and Washington State University College of Pharmacy.
Student proposals were judged by a panel of 75 NCPA members, Live Oak Bank and Good Neighbor Pharmacy coaching consultants, as well as business leaders.
FDA approves Aurobindo’s Loestrin generic line Aurovela
SILVER SPRING, Md. — The Food and Drug Administration has approved Aurobindo’s Aurovela — its line of five generic Loestrin products. The line of oral contraceptives are indicated to prevent pregnancy.
The products include:
- Aurovela Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets, 1.5 mcg/30 mcg, and ferrous fumarate tablets, 75 mg), a Loestrin Fe generic;
- Aurovela 24 Fe (norethindrone acetate and ethinyl estradiol tablets, 1 mcg/20 mcg, and ferrous fumarate tablets, 75 mg), a generic of Loestrin 24 Fe;
- Aurovela Fe 1/20 (norethindrone acetate and ethinyl estradiol tablets, 1 mcg/20 mcg, and ferrous fumarate tablets, 75 mg), a generic of Loestrin Fe 1/20;
- Aurovela 1/20 (norethindrone acetate and ethinyl estradiol tablets, 1 mcg/20 mcg); and
- Aurovela (norethindrone acetate and ethinyl estradiol tablets, 1.5 mcg/30 mcg).
The combined products have a market size of $315.9 million for the 12 months ended May 2017 according to QuintilesIMS data.